Leading with Extraordinary Clarity and Grace
En Español
Email Sign Up
Give
Search
En Español
Sign Up for Updates
Who We Are
About Us
Our Impact
Strategic Plan Highlights
Our History
Our Commitment to Community
Financials
Careers
Leadership and Partners
Board of Directors
Research Committee of the Board
Scientific Advisory Board
Leadership and Partners
Executive Staff
Young Leaders Board
About Lupus
What is Lupus?
Symptoms
How is Lupus Diagnosed?
Treatment
Educational Resources
Our Research
About Our Research
Research Roadmap
Research We Fund
Get Involved in Research
Lupus Nexus
Participate in the Lupus Landmark Study
Lupus Therapeutics, LLC
For Researchers
Funding Opportunities
Funded Research
Research Partners
Scientific Resources
Research Contacts
LRA Reviewers 2023–2024
Press
Stories & News
Get Involved
Give
Online Donation
Other Ways to Give
Sponsorship Opportunities
Research
Find a Clinical Trial
Give to the Lupus Brain Bank
Participate in the Lupus Landmark Study
Events
Host an Event
Past Events
Walks
Marathons
Advocate
Take Action
Steps We’ve Taken
Advocacy News
ManyOne Can
Accelerating Lupus Research
Contact
Stories & News
News and Stories
Leading with Extraordinary Clarity and Grace
Leading with Extraordinary Clarity and Grace The LRA is enormously grateful to Mary K. (Peggy) Crow, MD for her more...
News and Stories
Lupus News Corner
BIG … BOLD … IDEAS ARE TRANSFORMING LUPUS RESEARCH—thanks to people like you! Thanks to our remarkable supporters, the Lupus...
News and Stories
2019: A Year of Tremendous Growth
The Lupus Research Alliance (LRA) boldly pursued breakthroughs on the many fronts of lupus research in 2019—allowing the organization...
News and Stories
Moving Forward with Incredible Success
Taking a Closer Look at 2019 In the course of the year, the Lupus Research Alliance (LRA) took daring chances,...
News and Stories
Great News for Lupus Nephritis Treatment: Itolizumab Fast-Tracked by FDA
December 10, 2019
December 10, 2019 The Lupus Research Alliance (LRA) is pleased to share that a potential new treatment in development by...
News and Stories
Lupus Research Alliance Applauds Phase III Trial Results for Potential Lupus Nephritis Treatment
December 4, 2019 The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase III trial results for...
News and Stories
Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus
December 3, 2019 The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...
News and Stories
LRA Researchers Star at ACR/ARP – Part 2
Last week we gave you only half the story of what scientists funded by the Lupus Research Alliance (LRA)...
News and Stories
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019 The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...
News and Stories
The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals
November 12, 2019 The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation...
News and Stories
LRA-Funded Scientists Command Attention at 2019 ACR/ARP
November 14, 2019 The Lupus Research Alliance was proud of the unprecedented number of the studies supported by the Alliance...
News and Stories
Two Lupus Therapeutics Studies Report Positive Results at 2019 ACR/ARP Annual Meeting
November 12, 2019 Two positive clinical studies presented at the 2019 ACR/ARP Annual Meeting were conducted through the Lupus Clinical...
Posts pagination
◀︎
1
…
30
31
32
33
34
…
53
▶︎
Search Our Site
Search
X